scholarly journals The Expression of miR-155-5p and Local Matrix Gla Protein in Meningiomas

2021 ◽  
Vol 29 (3) ◽  
pp. 299-306
Author(s):  
Simona Roxana Gheorghe ◽  
Cătălin Marian ◽  
Ligia Gabriela Tătăranu ◽  
Anica Dricu ◽  
Cees Vermeer ◽  
...  
Keyword(s):  
Messenger Rna ◽  
Molecular Classification ◽  
Micro Rna ◽  
Matrix Gla Protein ◽  
World Health ◽  
Ectopic Calcification ◽  
Chain Reaction ◽  
The World ◽  
Polymerase Chain ◽  
Health Organization

Abstract Meningiomas are classified by the World Health Organization (WHO) in three grades, based on morphological features. Independent of this grading, the presence of calcification in meningiomas influences their growth rate. The messenger RNA of matrix Gla protein (MGP), an extra-hepatic protein with different conformations involved in the homeostasis of ectopic calcification has been found in meningiomas and was shown to be regulated in breast cancer by miR-155-5p, a specific micro RNA. Therefore, we investigated the expression of miR-155-5p and its relationship with local MGP conformations in different grade meningiomas. According to the WHO classification, our 41 samples of meningiomas were stratified in groups WHO I and WHO II. Using real time polymerase chain reaction, we observed a higher miR-155-5p expression in group WHO I versus group WHO II [with a fold change (FC) of 3.83, p=0.027)]. Moreover, the expression of miR-155-5p was higher in calcified tumors compared to non-calcified tumors in all samples (FC=3.01, p=0.047) and in group WHO I (FC=3.65, p=0.048). Utilizing immunohistochemistry, we determined the concurrent presence of all MGP conformations in calcified meningiomas. This study was the first to establish higher miR-155-5p expression in grade WHO I and calcified meningiomas, which could improve molecular classification and targeted therapy and also the presence of all MGP conformations in calcified meningiomas, confirming the existence of an anti-calcification mechanism in meningiomas..

scholarly journals Vulvar Tuberculosis—A Rare Manifestation of the Disease

2019 ◽  
Vol 41 (09) ◽  
pp. 575-578 ◽  
Author(s):  
Cristina Bragança ◽  
Inês Gonçalves ◽  
Luísa Guerreiro ◽  
Maria Janeiro
Keyword(s):  
Rare Case ◽  
Causes Of Death ◽  
World Health ◽  
Histological Findings ◽  
Chain Reaction ◽  
Rare Manifestation ◽  
The World ◽  
History Of ◽  
Polymerase Chain ◽  
Health Organization

AbstractTuberculosis is an infectious disease caused by Mycobacterium tuberculosis. According to data from the World Health Organization, this disease remains one of the leading causes of death worldwide. Although it most commonly affects the lungs, tuberculosis can compromise any organ. The present study reports a rare case of vulvar tuberculosis in a postmenopausal woman with a history of asymptomatic pulmonary and pleural tuberculosis, with no prior documented contact with the bacillus. Diagnosis was based on vulvar lesion biopsies, with histological findings suggestive of infection and isolation of M. tuberculosis by microbiological culture and polymerase chain reaction (PCR) essays. The lesions reverted to normal after tuberculostatic therapy.

Multisystem Inflammatory Syndrome in Infant with Negative SARS-CoV-2 RT-PCR and Antibodies

2021 ◽  
pp. 35-39
Author(s):  
Hanna Sahhar ◽  
Karly Derwitz ◽  
Erica Rubin
Keyword(s):  
Polymerase Chain Reaction ◽  
Severe Acute Respiratory Syndrome ◽  
Early Diagnosis ◽  
World Health ◽  
Rt Pcr ◽  
Chain Reaction ◽  
The World ◽  
Polymerase Chain ◽  
Health Organization ◽  
Inflammatory Syndrome

Since the declaration of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in March 2020 by the World Health Organization (WHO), there has been an emergence of a new syndrome termed multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. MIS-C is defined by the presence of fever, systemic inflammation and multiorgan dysfunction in association with SARS-CoV-2 infection or COVID-19 exposure. Knowledge of this syndrome’s presentation and pathophysiology is constantly evolving as more cases are reported in the literature. This case identifies a 3-month-old patient who tested negative for SARS-CoV-2 antigen, reverse transcriptase polymerase chain reaction (RT-PCR) and antibodies but qualified for MIS-C diagnosis. To the best of our knowledge and through extensive research at the time of diagnosing and reporting this condition to the healthcare authorities, we report the youngest pediatric patient with MIS-C diagnosis. We document this case to contribute to further understanding the variable manifestations of MIS-C and the importance of early diagnosis and treatment with intravenous immunoglobulin (IVIG).

scholarly journals PERBANDINGAN DETEKSI PLASMODIUM SPP ANTARA METODE IMMUNOCHROMATOGRAPHIC ASSAY DENGAN METODE POLYMERASE CHAIN REACTION

2014 ◽  
Vol 2 (1) ◽  
Author(s):  
Johanes Nyoman D. Widiswara Mawan
Keyword(s):  
Polymerase Chain Reaction ◽  
Sensitivity And Specificity ◽  
World Health ◽  
Immunochromatographic Assay ◽  
Chain Reaction ◽  
Genus Plasmodium ◽  
The World ◽  
Rapid Tests ◽  
Polymerase Chain ◽  
Health Organization

Abstract: Malaria is caused by protozoa of the genus Plasmodium remains a health problem in the world, especially in tropical countries and subtropical. Incidence of malaria from the World Health Organization (WHO) shows that in 2010 as many as 219 million cases of clinical malaria episodes show and 660,000 of them died. Therefore we need a means of early diagnosis has a sensitivity and specificity are good. This study compared the sensitivity and specificity of detection of Plasmodium spp using Immunochromatographic Assay method commonly known as rapid inspection test and Polymerase Chain Reaction (PCR). This study is a diagnostic test with a sample of 30 people who were taken with random sampling method in malaria patients who come to Budi Mulia Hospital since September 2013 - November 2013. The sample is a blood specimen taken at the brachial vein previously given informed consent in patients with the triad of symptoms of malaria in the area of ​​Bitung, Manado. From the blood samples examined by PCR. The results of the rapid tests and PCR in the detection of Plasmodium spp diagnostic test is then performed to determine the level of sensitivity and specificity. Result: The level of sensitivity of rapid tests in general by 89,2%, specificity of 100%, a positive predictive value of 100% and a negative predictive value of 40%. Conclusions: The sensitivity is moderate but has high specificity. Keywords:   Immunochromatographic Assay, Polymerase Chain Reaction (PCR), rapid tests, sensitivity, specificity  Abstrak: Malaria yang disebabkan oleh protozoa dari genus Plasmodium masih menjadi masalah kesehatan di dunia terutama di negara- negara tropis dan subtropis. Kejadian malaria dari World Health Organization (WHO) menunjukan bahwa pada 2010 sebanyak 219 juta kasus menunjukan episode klinik malaria dan 660.000 diantaranya meninggal dunia. Oleh karena itu diperlukan suatu alat diagnosa dini yang memiliki sensitivitas dan spesifisitas yang yang baik. Penelitian ini membandingkan tingkat sensitivitas dan spesifisitas deteksi Plasmodium spp dengan menggunakan metode Immunochromatographic Assay yang biasa dikenal dengan pemeriksaan rapid tes dan Polymerase Chain Reaction (PCR). Penelitian ini merupakan penelitian uji diagnostik dengan sampel sejumlah 30 orang yang diambil secara random sampling pada pasien malaria yang datang ke RSU Budi Mulia sejak bulan September 2013 - November 2013. Sampel adalah spesimen darah yang diambil pada vena brachialis yang sebelumnya telah diberikan inform consent pada pasien dengan gejala trias malaria di daerah Bitung, Manado. Dari sampel darah tersebut dilakukan pemeriksaan dengan PCR. Hasil dari rapid tes dengan metode Immunochromatographic dan PCR dalam mendeteksi Plasmodium spp selanjutnya dilakukan uji diagnostik untuk mengetahui tingkat sensitivitas dan spesifisitasnya. Hasil : Tingkat sensitivitas rapid tes secara umum sebesar 89,2%, spesifisitas sebesar 100%, nilai duga positif sebesar 100% dan nilai duga negatif sebesar 40%. Simpulan: Nilai sensitivitas yang sedang tetapi  memiliki  nilai spesifisitas  yang tinggi. Kata Kunci : Immunochromatographic Assay, Polymerase Chain Reaction (PCR), rapid tes, sensitivitas, spesifisitas

scholarly journals SARS-CoV-2; What We Know so far

2020 ◽  
Vol 23 (7) ◽  
pp. 498-502 ◽  
Author(s):  
Huda Fatima Rajani ◽  
Fatima Ahmed Alshaikh ◽  
Amir Anushiravani
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Diagnostic Methods ◽  
World Health ◽  
Chain Reaction ◽  
The World ◽  
Recent Outbreak ◽  
Control And Prevention ◽  
Polymerase Chain ◽  
Precautionary Measures ◽  
Health Organization

A recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 1100000 (April 5, 2020) individuals worldwide and is spreading rapidly. The virus is reported to be derived from bats and the infection was first reported in China. Similar to the severe acute respiratory syndrome and the Middle East respiratory syndrome coronaviruses, it is responsible for respiratory tract infection. Real time polymerase chain reaction and radiography are the two main diagnostic methods. Guidelines from the Center for Disease Control and Prevention and the World Health Organization (WHO) should be followed for diagnostic and precautionary measures. Treatment of the infection is still not available; however, antivirals are under clinical trials.

scholarly journals Difficulties in HAM/TSP diagnosis

2012 ◽  
Vol 70 (9) ◽  
pp. 686-690 ◽  
Author(s):  
Carla Maria Sena Andrade Slater ◽  
Luiz Claudio Pereira Ribeiro ◽  
Marzia Puccioni-Sohler
Keyword(s):  
Polymerase Chain Reaction ◽  
Cerebrospinal Fluid ◽  
Laboratory Diagnosis ◽  
World Health ◽  
Chain Reaction ◽  
Laboratory Findings ◽  
The World ◽  
Polymerase Chain ◽  
Health Organization ◽  
Probable Diagnosis

The World Health Organization recommends the use of Osame's criterion (1990) for the diagnosis of HTLV-I-associated myelopathy (HAM/TSP). In 2006, a group of neurologists developed a Brazilian criterion that can diagnose HAM/TSP from its onset. OBJECTIVE: It was to test the agreement between both criteria. METHODS: The study included evaluation of clinical and laboratory findings of 35 patients. The ELISA, Western blot and/or polymerase chain reaction was used to search for anti-HTLV-I antibodies. The analysis of agreement was based on the calculation of Kappa. RESULTS: Concordance of 100% (Kappa=1) occurred in cases of "defined" HAM/TSP, but not in patients with "probable" diagnosis. CONCLUSION: The Brazilian criteria was as effective as Osame's criteria for the diagnosis of "defined" HAM/TSP. However, both require more specific biological markers in cerebrospinal fluid for the laboratory diagnosis of probable cases.

scholarly journals Contribution of CT Features in the Diagnosis of COVID-19

2020 ◽  
Vol 2020 ◽  
pp. 1-16
Author(s):  
Houdong Zuo
Keyword(s):  
World Health ◽  
Rt Pcr ◽  
Chain Reaction ◽  
The World ◽  
Novel Virus ◽  
Polymerase Chain ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Diagnostic Criterion ◽  
Ct Features

The outbreak of novel coronavirus disease 2019 (COVID-19) first occurred in Wuhan, Hubei Province, China, and spread across the country and worldwide quickly. It has been defined as a major global health emergency by the World Health Organization (WHO). As this is a novel virus, its diagnosis is crucial to clinical treatment and management. To date, real-time reverse transcription-polymerase chain reaction (RT-PCR) has been recognized as the diagnostic criterion for COVID-19. However, the results of RT-PCR can be complemented by the features obtained in chest computed tomography (CT). In this review, we aim to discuss the diagnosis and main CT features of patients with COVID-19 based on the results of the published literature, in order to enhance the understanding of COVID-19 and provide more detailed information regarding treatment.

scholarly journals “COVID 19- Two Waves & More” What Have We Learnt?

2021 ◽  
Vol 5 (12) ◽  
Author(s):  
Manuj Kumar Sarkar ◽  
Subhra Dey ◽  
Boudhayan Das Munshi
Keyword(s):  
World Health Organisation ◽  
Physical Distance ◽  
World Health ◽  
Chain Reaction ◽  
Tissue Paper ◽  
Hand Sanitizer ◽  
First Case ◽  
The World ◽  
Polymerase Chain ◽  
Bat Coronavirus

The first case of SARS-CoV2 admitted on 26th December 2019 in Central Hospital, Wuhan, China. Broncho-alveolar lavage and Polymerase chain reaction of the aspirate showed high abundance of a viral RNA which has 89.1 % nucleotide identity with bat coronavirus previously isolated in China. Soon human to human transmission was observed and the outbreak started spreading. World Health Organisation on 11th March 2020 declared it as pandemic. COVID 19, caused by SARS-CoV-2, a disease we are still struggling to contain. With vaccination drive throughout the world, though the severity in re-infection has come down, but there is still threat by the various variants which are arising from time to time in various countries. The most effective way of preventing the spread of the virus is to keep physical distance from others of at least 1 meter, wearing a well fitted mask, keep hands clean and use hand sanitizer frequently, stay in well ventilated place, avoid crowded place and cough into bent elbow or tissue paper and get vaccinated when once’s turn comes. Therefore, we urge people to follow COVID appropriate behaviour properly. Keywords: COVID 19, SARS-CoV2, COVID appropriate behaviour, Social Distancing

scholarly journals Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients

Viruses ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 1384
Author(s):  
Michael Zapor
Keyword(s):  
Pcr Amplification ◽  
World Health ◽  
Rt Pcr ◽  
Chain Reaction ◽  
Distinctive Features ◽  
Clinical Specimens ◽  
Polymerase Chain ◽  
Health Organization ◽  
Infectious Potential ◽  
Infective Potential

The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) that emerged in December 2019 as the causative agent of Coronavirus 2019 (COVID-19) and was declared a pandemic by the World Health Organization in March 2020 has several distinctive features, including extensive multiorgan involvement with a robust systemic inflammatory response, significant associated morbidity and mortality, and prolonged persistence of viral RNA in the clinical specimens of infected individuals as detected by Reverse Transcription Polymerase Chain Reaction (RT-PCR) amplification. This review begins with an overview of SARS-CoV-2 morphology and replication and summarizes what is known to date about the detection of the virus in nasal, oropharyngeal, and fecal specimens of patients who have recovered from COVID-19, with a focus on the factors thought to contribute to prolonged detection. This review also provides a discussion on the infective potential of this material from asymptomatic, pre-symptomatic, and convalescing individuals, to include a discussion of the relative persistence and infectious potential of virus in clinical specimens recovered from pediatric COVID-19 patients.

scholarly journals Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome

2020 ◽  
Vol 7 (6) ◽  
pp. 200636 ◽  
Author(s):  
Kashif Aziz Khan ◽  
Peter Cheung
Keyword(s):  
World Health ◽  
Current Standard ◽  
Policy Makers ◽  
Diagnostic Pcr ◽  
Diagnostic Assays ◽  
The World ◽  
Polymerase Chain ◽  
Pcr Assays ◽  
Health Organization ◽  
Viral Sequences

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; initially named as 2019-nCoV) is responsible for the recent COVID-19 pandemic and polymerase chain reaction (PCR) is the current standard method for its diagnosis from patient samples. This study conducted a reassessment of published diagnostic PCR assays, including those recommended by the World Health Organization (WHO), through the evaluation of mismatches with publicly available viral sequences. An exhaustive evaluation of the sequence variability within the primer/probe target regions of the viral genome was performed using more than 17 000 viral sequences from around the world. The analysis showed the presence of mutations/mismatches in primer/probe binding regions of 7 assays out of 27 assays studied. A comprehensive bioinformatics approach for in silico inclusivity evaluation of PCR diagnostic assays of SARS-CoV-2 was validated using freely available software programs that can be applied to any diagnostic assay of choice. These findings provide potentially important information for clinicians, laboratory professionals and policy-makers.

scholarly journals COVID-19 testing: Essential for tracking infection and helping authority to overcome the challenges of spread

2020 ◽  
Vol 10 (2) ◽  
pp. 90-92
Author(s):  
Rano Mal Piryani ◽  
Suneel Piryani ◽  
Shomeeta Piryani ◽  
Ganesh Dangal ◽  
Muzaherul Huq ◽  
...  
Keyword(s):  
Polymerase Chain Reaction ◽  
World Health Organization ◽  
Blood Sample ◽  
Ribonucleic Acid ◽  
World Health ◽  
Chain Reaction ◽  
Infected People ◽  
Highly Sensitive ◽  
Polymerase Chain ◽  
Health Organization

COVID-19 is mainly transmitted through droplet infection and spread very fast compared to SARS-CoV and MERS-CoV. For the countries, it is important to know at what stage the COVID-19 epidem­ic is? So, as to take appropriate steps to contain the epidemic. This will only be known by testing the suspects and contacts of confirmed cases. If there is poor testing, then most of the infected people may remain undetected, however they could spread the virus to hundreds of other people and potential contacts, which could not be known and quarantined in time continuing the spread. If there is quality assured, highly sensitive and specific testing along with adequate isolation and quarantine, then the spread will be limited. There are two types of tests available for COVID-19: the tests directly detecting the viral ribonucleic acid (RNA) collected in nasopharyngeal or throat swabs, and tests detecting antibodies from the blood sample. At this point in time, the polymerase chain reaction (PCR) tests are used for confirmation of the disease while antibodies tests may provide information regarding the prevalence of infection. World Health Organization advices the countries to increase the testing and get to know the level of epidemic and act accordingly for containment of infection.

Sign in / Sign up

Export Citation Format

Share Document